Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Immuneering Corp Cl A (IMRX)

Immuneering Corp Cl A (IMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Immuneering Corporation Forms Pancreatic Cancer Advisory Board to Advance IMM-1-104 Development Quiver Quantitative, Inc. - Thu Dec 19, 5:24PM CST

Immuneering Corporation establishes a Pancreatic Cancer Advisory Board to enhance clinical guidance for its lead candidate, IMM-1-104.Quiver AI SummaryImmuneering Corporation has established a Pancreatic...

IMRX : 2.00 (+8.70%)
From Crisis to Opportunity: How Advances in Immunotherapy Are Shaping the Oncology Sector BayStreet.ca - Thu Dec 19, 12:59PM CST

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – Despite significant advances in oncology research, challenges remain as the American Cancer Society...

ONCY : 0.8310 (-6.36%)
PYXS : 1.6900 (+9.74%)
RPTX : 1.3200 (unch)
IMRX : 2.00 (+8.70%)
CVM : 0.7299 (-4.60%)
ONC.TO : 1.19 (-9.16%)
Immuneering Launches Pancreatic Cancer Advisory Board GlobeNewswire - Thu Dec 19, 7:00AM CST

IMRX : 2.00 (+8.70%)
Immuneering to Present Data from Three Arms of its Ongoing Phase 2a Trial of IMM-1-104 in Early January 2025 GlobeNewswire - Tue Dec 17, 7:00AM CST

IMRX : 2.00 (+8.70%)
Immuneering Corporation Receives FDA Fast Track Designation for IMM-1-104 in Advanced NRAS-Mutant Melanoma Quiver Quantitative, Inc. - Thu Dec 12, 5:24PM CST

IMM-1-104 shows promise for melanoma patients after immune checkpoint inhibitors, with favorable tolerability in Phase 1 trials.Quiver AI SummaryImmuneering Corporation announced that its lead candidate...

IMRX : 2.00 (+8.70%)
Immuneering Granted FDA Fast Track Designation for IMM-1-104 in Advanced Melanoma GlobeNewswire - Thu Dec 12, 7:00AM CST

IMRX : 2.00 (+8.70%)
Immuneering Corporation to Present at Piper Sandler 36th Annual Healthcare Conference Quiver Quantitative, Inc. - Wed Nov 27, 5:20PM CST

Immuneering Corporation will present its oncology pipeline and business strategy at the Piper Sandler Healthcare Conference on December 5, 2024.Quiver AI SummaryImmuneering Corporation, a clinical-stage...

IMRX : 2.00 (+8.70%)
Immuneering to Present at the Piper Sandler 36áµ—Ê° Annual Healthcare Conference GlobeNewswire - Wed Nov 27, 7:00AM CST

IMRX : 2.00 (+8.70%)
Immuneering Reports Third Quarter 2024 Financial Results and Provides Business Updates GlobeNewswire - Wed Nov 13, 3:05PM CST

IMRX : 2.00 (+8.70%)
Immuneering Granted Orphan Drug Designation for IMM-1-104 by FDA in the Treatment of Pancreatic Cancer GlobeNewswire - Tue Oct 15, 7:00AM CDT

IMRX : 2.00 (+8.70%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot